Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
The New England journal of medicine.
Times cited: 2
- Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood. 2006 Academic Article GET IT
- Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML). Blood. 2005 Academic Article GET IT
Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
Times cited: 60